Darwin Wealth Management’s NantHealth, Inc NH Stock Holding History

Darwin Wealth Management’s Portfolio NH Stock Details NH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-80	Closed	-$1K	–	851
2020 Q1	$1K	Buy	+80	New	+$1.92K	﹤0.01%	781

Other funds holding NH

DCM

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MMA

Miracle Mile Advisors Los Angeles, California $8.53B AUM 21.43% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Darwin Wealth Management's NH Position: Q2 2020 in Review

Darwin Wealth Management sold out of NantHealth, Inc (NH) in Q2 2020, closing a stake of 80 shares — an estimated $1K sold.

Darwin Wealth Management first reported a position in NH in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 44 funds tracked by Wall St. Rank hold NH as of Q2 2020.

Darwin Wealth Management reported no remaining NantHealth, Inc position as of Q2 2020 after selling out during the quarter.
Darwin Wealth Management sold 80 NantHealth, Inc shares in Q2 2020, an estimated $1K.
Darwin Wealth Management first reported a position in NantHealth, Inc in Q1 2020 and held it in 1 quarter.
Darwin Wealth Management's NantHealth, Inc position peaked at $1K in Q1 2020.
44 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2020.

Based on Darwin Wealth Management's 13F filing for Q2 2020, filed 6 Aug 2020.